Skip to main content
Clinical Trials/NL-OMON25231
NL-OMON25231
Completed
Not Applicable

Efficacy of RhDNase targeted to the peripheral airways in CF exacerbations.A randomized controlled clinical trial.

Roche Nederland B.V.0 sites40 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Roche Nederland B.V.
Enrollment
40
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

/A

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • The criteria of inclusion will be the following:
  • 1\. Age between 6 and 18 years old;

Exclusion Criteria

  • The following exclusion criteria will be used:
  • 1\. Inability to follow instructions of the investigator;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhood.asthma with persistent obstructive pulmonary function.
NL-OMON21320ErasmusMC Rotterdam60
Active, not recruiting
Not Applicable
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhoodAsthma is a chronic inflammatory disorder in which many cells play a role, in particular mast cells, eosinophils and T lymphocytes. In susceptible individuals this inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness and cough. These symptoms are usually associated with widespread but variable airflow limitation that is at least partly reversible either spontaneously or with treatment.MedDRA version: 8.1Level: LLTClassification code 10003553Term: Asthma
EUCTR2006-002337-20-NLErasmus Medical Centre Rotterdam60
Completed
Not Applicable
Efficacy of peripherally targeted inhaled rhDNase for persistent obstructive asthma in childhoodObstructive pulmonary function, asthmaRespiratoryObstructive pulmonary disease, asthma
ISRCTN71537084Erasmus Medical Center (The Netherlands)60
Active, not recruiting
Not Applicable
‘Peripheral targeting of inhaled rhDNase in stable CF patients.’Cystic FibrosisMedDRA version: 9.1Level: LLTClassification code 10011762Term: Cystic fibrosisMedDRA version: 9.1Level: LLTClassification code 10011763Term: Cystic fibrosis lung
EUCTR2007-000935-25-NLErasmusMC - Sophia Children's Hospital50
Completed
Not Applicable
Peripheral targeting of inhaled rhDNase in stable CF patients.Cystic Fibrosis (CF)10038716
NL-OMON33580Erasmus MC, Universitair Medisch Centrum Rotterdam25